phase ii study investigating the efficacy of daratumumab in patients with stage 3b al amyloidosis
Published 1 year ago • 70 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
0:53
acusera serum indices control
-
3:20
phase i trial of a bcma-cd3 bispecific antibody in r/r myeloma
-
3:30
sc vs. iv administration of a bcma-cd3 bispecific antibody for r/r myeloma
-
1:43
eradic trial: preliminary results of mrd-guided ibrutinib plus venetoclax vs fcr
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
1:14:09
acusera 24•7 webinar: utilisation of qc software and metrics to help identify performance issues
-
11:58
rcsi & ucd malaysia campus
-
26:19
rnl 2021 - eular 2019 and acr 2020 ra treatment guidelines - dr. alan matsumoto
-
1:21
chep-bv followed by bv consolidation in cd30-expressing ptcl
-
1:36
rechallenge with egfr inhibitors in ctdna ras/braf wt refractory mcrc
-
2:05
digams: digital antimicrobial resistance platform
-
0:54
neo-checkray: chemotherapy and sbrt with durvalumab and oleclumab in er /her2- breast cancer
-
1:02
lateral disc herniations mri and ct
-
1:02
subtle findings ankle & foot: 3 cases from this week
-
2:14
encephalitis and subarachnoid hemorrhages in a case of aplastic anaemia.
-
13:58
treatment options for skin cancer of the head and neck
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
1:56
arasens: dialuramide plus adt and docetaxel for metastatic hormone-sensitive prostate cancer
-
58:21
rumc gobeyond : keynote speaker series 2021 (preventing diabetes)
-
2:18
the importance of ang-2 in retinal and choroidal vascular diseases
-
1:05
chiari network@ to drahmadmirdamadi?si=fjucc8svfl3rimtd
-
2:29
combo of rg6146/venetoclax/rituximab for r/r dlbcl: initial data